STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: AbSorber, a LinkMed portfolio company, got its transplantation crossmatch test XM-ONE® evaluated in a large clinical study and the results are now published in the prestigious international medical journal Transplantation. The study shows that XM-ONE® contributes valuable information that refines the diagnostics for finding the right organ for the right patient, thereby increasing the probability of a successful transplantation. Four U.S. and two Swedish well-reputed hospitals participated in the multicenter trial.
